| Name | Title | Contact Details |
|---|
Unlike traditional approaches that only address symptoms, Cardionomic addresses the conditions root cause of reduced contractility. The therapy uses neuromodulation to benignly increase contractility, thus improving cardiac output therefore increasing renal flow and end organ perfusion. Benignly increasing contractility decreases negative hormonal signaling, and improves in-hospital morbidity/mortality. This breakthrough therapy is also expected to increase pharmacological tolerance at discharge, which will reduce costly readmission and extend life. Spun off from Denali Medical II, a New Enterprise Associates (NEA) backed incubator, Cardionomic is funded by NEA, Greatbatch Medical and Cleveland Clinic Foundation.
iCarbonX is building a digital life ecosystem by combining consumer life data, the Internet and artificial intelligence.
Olympus is a pioneer in establishing a very high standard of service for international patients. We have established a network composed of premier health care providers that includes over 4,000 hospitals in 58 countries. Our services are offered to
Disability Management Network is a Forest Park, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Expeditor Systems is a Alpharetta, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.